Corbus Pharmaceuticals Holdings Inc. (CRBP)

7.25
NASDAQ : Health Technology
Prev Close 7.80
Day Low/High 7.00 / 7.79
52 Wk Low/High 4.50 / 9.96
Avg Volume 1.24M
Exchange NASDAQ
Shares Outstanding 57.21M
Market Cap 446.21M
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

First Week Of November 16th Options Trading For Corbus Pharmaceuticals Holdings (CRBP)

First Week Of November 16th Options Trading For Corbus Pharmaceuticals Holdings (CRBP)

Investors in Corbus Pharmaceuticals Holdings Inc saw new options become available this week, for the November 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRBP options chain for the new November 16th contracts and identified one put and one call contract of particular interest.

Can Corbus Pharmaceuticals Hold Its Gains?

Can Corbus Pharmaceuticals Hold Its Gains?

CRBP rocketed 53% Thursday on news of a deal with Jenrin Discovery to study 600 of their cannabinoid compounds.

Real-Deal Rally: Cramer's 'Mad Money' Recap (Thursday 9/20/18)

Real-Deal Rally: Cramer's 'Mad Money' Recap (Thursday 9/20/18)

Jim Cramer says the fundamentals in the U.S. are good, and some stocks are still cheap. Keep calm and rally on.

Trading Hot Sectors Like Cannabis Regardless of Valuations

Trading Hot Sectors Like Cannabis Regardless of Valuations

These speculative frenzies all have a number of things in common.

Cannabis Frenzy Continues With New Age Beverages and Corbus Pharmaceuticals

Cannabis Frenzy Continues With New Age Beverages and Corbus Pharmaceuticals

Aggressive traders are beating the bushes looking for the next big mover.

We’re Watching Pot Stock Corbus Pharma, But Aren’t Fired Up Yet

The company seems intriguing, but needs to give us more buzz.

Corbus Pharmaceuticals Holdings Becomes Oversold (CRBP)

Corbus Pharmaceuticals Holdings Becomes Oversold (CRBP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Corbus Pharmaceuticals Holdings Is Now Oversold (CRBP)

Corbus Pharmaceuticals Holdings Is Now Oversold (CRBP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting CRBP Put And Call Options For January 2019

Interesting CRBP Put And Call Options For January 2019

Investors in Corbus Pharmaceuticals Holdings Inc saw new options become available this week, for the January 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 228 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

New 52-Week Low Could Prompt More Insider Buying At CRBP

In trading on Friday, shares of Corbus Pharmaceuticals Holdings Inc touched a new 52-week low of $5.15/share. That's a $4.81 share price drop, or -48.29% decline from the 52-week high of $9.96 set back on 01/30/2018.

Relative Strength Alert For Corbus Pharmaceuticals Holdings

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting CRBP Call Options For May 18th

Interesting CRBP Call Options For May 18th

Investors in Corbus Pharmaceuticals Holdings Inc saw new options become available this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRBP options chain for the new May 18th contracts and identified the following call contract of particular interest.

Corbus Pharmaceuticals Holdings Stock Sees Short Interest Make 22.7% Move

Corbus Pharmaceuticals Holdings Stock Sees Short Interest Make 22.7% Move

The most recent short interest data has been released for the 02/15/2018 settlement date, which shows a 1,617,885 share increase in total short interest for Corbus Pharmaceuticals Holdings Inc , to 8,757,760, an increase of 22.66% since 01/31/2018. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Trimming a Semiconductor Name

At the same time we are raising Pixelworks' price target to $8 from $6.50.

Keep Buying Pot Stocks; Weed Isn't Going Away

Keep Buying Pot Stocks; Weed Isn't Going Away

Selloffs like the one in marijuana stocks present entry points, if this is your cup of tea.

Interesting CRBP Put And Call Options For February 16th

Interesting CRBP Put And Call Options For February 16th

Investors in Corbus Pharmaceuticals Holdings Inc saw new options begin trading this week, for the February 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRBP options chain for the new February 16th contracts and identified one put and one call contract of particular interest.

Trimming a Biotech; Adding 2 Bullpen Names

We'll sell some Inovio Pharma on recent strength and put 2 'pot names,' Kush Bottles and Corbus Pharmaceuticals, in the Bullpen.

How to Invest in America's Legal Weed Trend Through Marijuana Stocks

How to Invest in America's Legal Weed Trend Through Marijuana Stocks

Recreational use of marijuana is now legal in California, but don't get lost among the weeds of stocks.

California Dreamin': Searching for a 'Pot' of Gold Through Marijuana Stocks

California Dreamin': Searching for a 'Pot' of Gold Through Marijuana Stocks

On Monday, recreational use of marijuana will be legal in California, so let's visit 3 weed stocks.

Short Interest Makes 10.4% Move For CRBP

Short Interest Makes 10.4% Move For CRBP

The most recent short interest data has been released for the 11/15/2017 settlement date, which shows a 658,457 share increase in total short interest for Corbus Pharmaceuticals Holdings Inc , to 6,968,817, an increase of 10.43% since 10/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Interesting CRBP Put And Call Options For December 15th

Interesting CRBP Put And Call Options For December 15th

Investors in Corbus Pharmaceuticals Holdings Inc saw new options become available this week, for the December 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRBP options chain for the new December 15th contracts and identified one put and one call contract of particular interest.

Commit To Purchase Corbus Pharmaceuticals Holdings At $5, Earn 15.4% Annualized Using Options

Commit To Purchase Corbus Pharmaceuticals Holdings At $5, Earn 15.4% Annualized Using Options

Investors eyeing a purchase of Corbus Pharmaceuticals Holdings Inc stock, but tentative about paying the going market price of $6.97/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2018 put at the $5 strike, which has a bid at the time of this writing of 40 cents.

Commit To Buy Corbus Pharmaceuticals Holdings At $5, Earn 17.2% Annualized Using Options

Commit To Buy Corbus Pharmaceuticals Holdings At $5, Earn 17.2% Annualized Using Options

Investors considering a purchase of Corbus Pharmaceuticals Holdings Inc stock, but tentative about paying the going market price of $6.42/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $5 strike, which has a bid at the time of this writing of 25 cents.

Oversold Conditions For Corbus Pharmaceuticals Holdings (CRBP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Did Corbus Investors Get Thrown Off by a Red Herring?

Did Corbus Investors Get Thrown Off by a Red Herring?

Investors ran for the exits after analysts pointed out that glowing Phase 2 study results for Corbus actually weren't that great. But a better story lies behind this biotech play.

Home Depot, Federal Realty, more: 'Mad Money' Lightning Round

Home Depot, Federal Realty, more: 'Mad Money' Lightning Round

Jim Cramer is bullish on Home Depot, Corbus Pharmaceuticals, Federal Realty and Vector Group.

Market Stays Strong in the Fight: Cramer's 'Mad Money' Recap (Friday 4/7/17)

Market Stays Strong in the Fight: Cramer's 'Mad Money' Recap (Friday 4/7/17)

Even with a trifecta of worries, stocks hold tight thanks to decisive U.S. action in Syria, says Jim Cramer.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Corbus Pharmaceuticals Holdings, Inc.

Levi & Korsinsky announces it has commenced an investigation of Corbus Pharmaceuticals Holdings, Inc.

TheStreet Quant Rating: D (Sell)